Comprehensive Evaluation of Safety and Efficacy of Cefazolin and Cefazolin Sodium Pentahydrate for Treating Infection in Children

A Retrospective Analysis of the Efficacy and Safety of Cefazolin and Cefazolin Sodium Pentahydrate for Treating Infection in Children

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017572

Enrollment

Unknown

Registered

2018-08-04

Start date

2018-08-31

Completion date

Unknown

Last updated

2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infection

Interventions

Group 1:Cefazolin

Group 2:cefazolin sodium pentahydrate

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1) Clear diagnosis of infection; (2) No antibacterial drugs and traditional Chinese medicine preparations with antibacterial activity before admission

Exclusion criteria

Exclusion criteria: (1) Patients with severe liver and renal insufficiency; (2) Patients who have long used immunosuppressive agents and glucocorticoids; (3) Incomplete information and case data; (4) pregnant or lactating women; (5) Infants and young children.

Design outcomes

Primary

Measure	Time frame
symptoms;Bacteriological examination;	—

Countries

China

Contacts

Public ContactZhiping Li

Children's Hospital of Fudan University

zhipinglifudan@yeah.net+86 18017590744

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026